Viewing Study NCT05235906


Ignite Creation Date: 2025-12-26 @ 5:23 PM
Ignite Modification Date: 2026-01-22 @ 9:42 AM
Study NCT ID: NCT05235906
Status: UNKNOWN
Last Update Posted: 2023-08-09
First Post: 2022-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer
Sponsor:
Organization: